Literature DB >> 23616788

Neuronal toxicity in HIV CNS disease.

Jane Kovalevich1, Dianne Langford.   

Abstract

HIV enters the brain during the early stages of initial infection and can result in a complicated array of diverse neurological dysfunctions. While neuronal injury and loss are at the heart of neurological decline and HIV-associated neuropathology, HIV does not productively infect neurons and the effects of HIV on neurons may be described as largely indirect. Viral proteins released from infected cells in the CNS are a well-characterized source of neuronal toxicity. Likewise, host-derived inflammatory cytokines and chemokines released from infected and/or activated glial cells can damage neurons, as well. Newly identified host-virus interactions and the current state of our knowledge regarding HIV-associated neuronal toxicity will be addressed in this review. Aspects of HIV-associated neurotoxic mechanisms, patterns of neuronal damage, viral effects on neurotrophic signaling, clade variations and comorbid substance abuse will be discussed. Recent advances in our understanding of the impact of HIV infection of the CNS on neuronal dysfunction and cell death will also be highlighted.

Entities:  

Keywords:  CNS; HIV-associated neurocognitive disorders; blood–brain barrier; cART; excitotoxicity; inflammation; neurons; synaptodendritic

Year:  2012        PMID: 23616788      PMCID: PMC3632417          DOI: 10.2217/fvl.12.57

Source DB:  PubMed          Journal:  Future Virol        ISSN: 1746-0794            Impact factor:   1.831


  126 in total

1.  Molecular mimicry between HIV-1 gp41 and an astrocyte isoform of alpha-actinin.

Authors:  T Spehar; M Strand
Journal:  J Neurovirol       Date:  1995-12       Impact factor: 2.643

Review 2.  HIV-1 pathogenesis.

Authors:  Mario Stevenson
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

Review 3.  Tat-induced deregulation of neuronal differentiation and survival by nerve growth factor pathway.

Authors:  Francesca Peruzzi; Jennifer Gordon; Nune Darbinian; Shohreh Amini
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

Review 4.  Neurocognitive dysfunction in the highly active antiretroviral therapy era.

Authors:  Nomvuyo Z Mothobi; Bruce J Brew
Journal:  Curr Opin Infect Dis       Date:  2012-02       Impact factor: 4.915

5.  Morphine potentiates HIV-1 gp120-induced neuronal apoptosis.

Authors:  Shuxian Hu; Wen S Sheng; James R Lokensgard; Phillip K Peterson
Journal:  J Infect Dis       Date:  2005-02-10       Impact factor: 5.226

6.  Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry.

Authors:  O Bagasra; E Lavi; L Bobroski; K Khalili; J P Pestaner; R Tawadros; R J Pomerantz
Journal:  AIDS       Date:  1996-06       Impact factor: 4.177

7.  Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons.

Authors:  Sylvia Fitting; Ruqiang Xu; Cecilia Bull; Shreya K Buch; Nazira El-Hage; Avindra Nath; Pamela E Knapp; Kurt F Hauser
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

8.  HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells.

Authors:  G Zauli; P Secchiero; L Rodella; D Gibellini; P Mirandola; M Mazzoni; D Milani; D R Dowd; S Capitani; M Vitale
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

9.  Signalling properties of an HIV-encoded angiogenic peptide mimicking vascular endothelial growth factor activity.

Authors:  P Scheidegger; W Weiglhofer; S Suarez; S Console; J Waltenberger; M S Pepper; R Jaussi; K Ballmer-Hofer
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

10.  In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-alpha RNA in the central nervous system.

Authors:  G J Nuovo; F Gallery; P MacConnell; A Braun
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

View more
  40 in total

1.  Rabies virus envelope glycoprotein targets lentiviral vectors to the axonal retrograde pathway in motor neurons.

Authors:  James N Hislop; Tarin A Islam; Ioanna Eleftheriadou; David C J Carpentier; Antonio Trabalza; Michael Parkinson; Giampietro Schiavo; Nicholas D Mazarakis
Journal:  J Biol Chem       Date:  2014-04-21       Impact factor: 5.157

2.  The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer's disease.

Authors:  Leah H Rubin; Erin E Sundermann; David J Moore
Journal:  J Neurovirol       Date:  2019-01-22       Impact factor: 2.643

Review 3.  Role of endolysosomes and inter-organellar signaling in brain disease.

Authors:  Zahra Afghah; Xuesong Chen; Jonathan D Geiger
Journal:  Neurobiol Dis       Date:  2019-11-09       Impact factor: 5.996

Review 4.  Glutamate metabolism and HIV-associated neurocognitive disorders.

Authors:  Fabián J Vázquez-Santiago; Richard J Noel; James T Porter; Vanessa Rivera-Amill
Journal:  J Neurovirol       Date:  2014-05-28       Impact factor: 2.643

Review 5.  Gene Editing for Treatment of Neurological Infections.

Authors:  Martyn K White; Rafal Kaminski; Hassen Wollebo; Wenhui Hu; Thomas Malcolm; Kamel Khalili
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

6.  Human Immunodeficiency Virus Type 1 gp120 and Tat Induce Mitochondrial Fragmentation and Incomplete Mitophagy in Human Neurons.

Authors:  Carmen Teodorof-Diedrich; Stephen A Spector
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

7.  Envelope gene evolution and HIV-1 neuropathogenesis.

Authors:  Fabián J Vázquez-Santiago; Vanessa Rivera-Amill
Journal:  J Neuroinfect Dis       Date:  2015-08-20

Review 8.  Role of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disorders.

Authors:  Jerel Fields; Wilmar Dumaop; T D Langford; Edward Rockenstein; E Masliah
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-08       Impact factor: 4.147

9.  Characterization of neuropathology in the HIV-1 transgenic rat at different ages.

Authors:  William C Reid; Wael G Ibrahim; Saejeong J Kim; Frank Denaro; Rafael Casas; Dianne E Lee; Dragan Maric; Dima A Hammoud
Journal:  J Neuroimmunol       Date:  2016-02-03       Impact factor: 3.478

10.  HIV-1 Tat and Cocaine Impair Survival of Cultured Primary Neuronal Cells via a Mitochondrial Pathway.

Authors:  Francesca Isabella De Simone; Nune Darbinian; Shohreh Amini; Madesh Muniswamy; Martyn K White; John W Elrod; Prasun K Datta; Dianne Langford; Kamel Khalili
Journal:  J Neuroimmune Pharmacol       Date:  2016-03-31       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.